Menu

Opinion: Why I Published in a Predatory Journal

Our totally bogus case report swiftly passed muster, with only minor revisions requested.

Apr 6, 2017
John H. McCool

© DUSAN PETRICICEarlier this year, I was invited to submit a paper to a dubious urology journal. I’m not a physician, much less a urologist. But I am an editor of scientific writing who has a strong antipathy for predatory journals. I’m also a Seinfeld fanatic.

So I decided to troll this publication, the MedCrave Group’s Urology & Nephrology Open Access Journal, to see whether they would agree to publish a totally made-up, Seinfeld-themed “case report” about a man who develops “uromycitisis poisoning.” This was inspired by the classic 1991 episode, “The Parking Garage,” in which Jerry Seinfeld can’t find his car in a mall lot, has to urinate, does so against a garage wall, is caught by a security guard, and tries to get out of a citation by claiming that he suffers from a condition called uromycitisis. Seinfeld argued that, due to his illness, he could die if he doesn’t relieve himself when he feels the urge.

I went all out. I wrote my report as Dr. Martin van Nostrand, the physician-alter ego of another Seinfeld character, and listed more show-inspired names as bogus coauthors. I made an email account for Dr. van Nostrand and created a fake institution where the authors worked: the Arthur Vandelay Urological Research Institute. In the acknowledgments section of my report, I thanked phony physicians including Tor Eckman, the bizarre holistic healer from the Seinfeld episode “The Heart Attack,” giving him a Doctor of Holistic Medicine (HMD) degree. Basically, I wrote the manuscript in a style as close to a real case report as I could, except that it was 100 percent fake.

To my surprise, a representative at Urology & Nephrology Open Access Journal wrote to say that my manuscript had been sent out for peer review. Three days later, it was conditionally accepted. I was asked to make minor revisions—including trimming the abstract and including the phony patient’s lab results—and pay a “nominal” $799 fee, plus tax.

Continuing to dupe the publication, I did all that was asked—except remit payment—and, on March 31, my report was published on the journal’s website (PDF). I have no intention of paying the requested fee.

A simple Google search for “uromycitisis” or “Martin van Nostrand” returns thousands of references to Seinfeld. Checking just one of the “papers” I included in the manuscript’s reference section, the editors or reviewers could easily have determined it was fabricated.

Why did the journal publish a report so easily identifiable as fake? I’ll leave that to the publication to explain.

Why, you might ask, did I take this stunt as far as I did? For nearly a year, I have been on a personal mini-crusade against fake scientific journals, and I have written several articles on the topic. In 2016, I was invited to submit a paper to the Journal of Nanomedicine Research, which is also published by MedCrave. I posted an article on LinkedIn about this, but it was not widely read, nor effective at exposing the journal as dubious. So when the urology journal came calling, I thought a more-extreme trolling operation might be more effective. I wrote the fictitious case report over a weekend.

My short-term goal is to expose MedCrave as a publisher that will print fiction, for a price. My long-term goal—an ambitious one, I know—is to stop the production of predatory journals altogether. 

John H. McCool is the founder and senior scientific editor of Precision Scientific Editing, based in Houston, Texas. 

Editors note: Prior to publication of this article, The Scientist and Retraction Watch requested comment from Urology & Nephrology Open Access Journal/MedCrave Group, but did not receive a response on deadline.

See “Hello…Newman: Yet Another Sting Pranks a Predatory Journal, Seinfeld-style,” Retraction Watch, April 6, 2017

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.